Profile of infections in newly diagnosed patients with acute leukemia during the induction phase of treatment

Abstract EN

Background and Purpuse: Acute leukemia is the most common pediatric malignancy.

Despite the significant progress in the treatment of infectious complications, infection-related morbidity and mortality continue to be of great importance.

Prompt initiation of the appropriate empiric antibiotic treatment has improved infection outcome.

The aim of the present study is to assess the type, frequency, and severity of infectious complications in a cohort of pediatric cancer patients treated at a single medical institution.

We also aim to identify factors affecting bloodstream infections in newly diagnosed ALL and AML pediatric patients during the induction phase of treatment.

Patients and Methods : this study was carried out at the Department of Pediatric Oncology, National Cancer Institute, Cairo University, during the time period from January 1st to June 30th 2007.

Inclusion criteria were pediatric age group (from 0-16 years), newly diagnosed acute leukemia, positive blood culture and documented site of infection.

Data were analyzed using the SPSS package version 15.

A p-value £0.05 was considered significant.

Results : this is a retrospective study including 100 newly diagnosed cases of acute leukemia.

Fifty-four patients had ALL, and 46 patients had AML.

348 infectious episodes were recorded.

Blood stream infections (BSI) occurred once or twice in 32 %, 3-4 episodes in 58 %, and five or more episodes in 10 % of the cases.

Gram-positive cocci were the most frequently observed cause of BSI, accounting for 77.9 % of the total isolates followed by Gram negative organisms seen in 18.9 % and mixed infections in 8 %.

The majority of the episodes (n = 208, 58.4 %) responded to first-line empirical antibiotic therapy.

Conclusion : clinical and laboratory risk factors could be identified and can help prediction of serious BSI.